Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 9Neoplasm Metastasis 3Triple Negative Breast Neoplasms 2Neoplasms 2Breast Cancer With Brain Metastasis 2Pancreatic Neoplasms 1HER2 Overexpression 1Colorectal Neoplasms 1Brain Neoplasms 1Anatomic Stage IV Breast Cancer AJCC v8 1Advanced Solid Tumor 1Advanced Breast Cancer 1

Interventions

toripalimab 2trastuzumab deruxtecan 1tislelizumab 1envafolimab 1enfortumab vedotin 1conteltinib 1Pemetrexed 1Oxaliplatin 1Injections 1Gemcitabine 1Cisplatin 1Carboplatin 1Capecitabine 1CD3 Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Solid Tumor × trastuzumab deruxtecan × Clear all
NCT07157956 2025-09-05

CVL006-T1002

Convalife (Shanghai) Co., Ltd.

Phase 1/2 Not yet recruiting
318 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡